Data gathered: November 6
Alternative Data for Pfizer
About Pfizer
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
| Price | $27.36 |
| Target Price | Sign up |
| Volume | 64,550,000 |
| Market Cap | $159B |
| Year Range | $24.55 - $31.39 |
| Dividend Yield | 5.98% |
| PE Ratio | 37.51 |
| Analyst Rating | 33% buy |
| Industry | Drug Manufacturers |
In the news
 |
PFE or NVO: Which Is the Better Value Stock Right Now?November 5 - Yahoo |
 |
1 Green Flag That's Also a Red Flag for Pfizer StockNovember 4 - Yahoo |
 |
Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy Right Now?November 4 - Yahoo |
 |
Is Pfizer Stock a Bargain for Long-Term Investors?November 4 - Biztoc.com |
Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche., Daiichi Sankyo, Pfizer, and Gilead SciencesNovember 4 - GlobeNewswire |
|
 |
Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?November 4 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 17.7B | 8.72B | 8.98B | 4.47B | 6.78B | 1.060 |
| Q2 '24 | 13.3B | 8.41B | 4.88B | 41M | 1.99B | 0.600 |
| Q1 '24 | 14.9B | 8.28B | 6.6B | 3.12B | 5.5B | 0.820 |
| Q4 '23 | 14.2B | 18.1B | -3.89B | -3.37B | -2.28B | 0.100 |
| Q3 '23 | 13.5B | 12.6B | 625M | -2.38B | -1.45B | -0.170 |
Insider Transactions View All
| DAMICO JENNIFER B. filed to sell 8,582 shares at $28.7. August 14 '24 |
| Gottlieb Scott filed to buy 9,000 shares at $26.5. December 19 '23 |
| Gottlieb Scott filed to buy 6,000 shares at $38.6. May 9 '23 |
| DAMICO JENNIFER B. filed to sell 9,003 shares at $40. March 17 '23 |
| DAMICO JENNIFER B. filed to sell 10,846 shares at $54. June 8 '22 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Roger Williams |
Jun 12, 24 | Sell | $1K - $15K |
| Roger Williams |
Jun 12, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Buy | $15K - $50K |
Read more about Pfizer (PFE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Pfizer?
The Market Cap of Pfizer is $159B.
What is Pfizer's PE Ratio?
As of today, Pfizer's PE (Price to Earnings) ratio is 37.51.
What is the current stock price of Pfizer?
Currently, the price of one share of Pfizer stock is $27.36.
How can I analyze the PFE stock price chart for investment decisions?
The PFE stock price chart above provides a comprehensive visual representation of Pfizer's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pfizer shares. Our platform offers an up-to-date PFE stock price chart, along with technical data analysis and alternative data insights.
Does PFE offer dividends to its shareholders?
Yes, Pfizer (PFE) offers dividends to its shareholders, with a dividend yield of 5.98%. This dividend yield represents Pfizer's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Pfizer in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Pfizer?
Some of the similar stocks of Pfizer are Johnson & Johnson, Eli Lilly and Company, Astrazeneca, AbbVie, and TherapeuticsMD.
.